← Back to Search

Behavioural Intervention

Digital Clinic Arm for Alcoholism (DALC Trial)

N/A
Recruiting
Led By Douglas Simonetto, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

DALC Trial Summary

"This trial aims to see if using a digital clinic with multiple specialists can help improve health outcomes, lower costs, increase access to care, and make healthcare providers happier. The main goal is to improve outcomes

Who is the study for?
This trial is for individuals with alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). It's designed to see if a digital clinic can help improve their health outcomes. Participants should be comfortable using digital tools for treatment.Check my eligibility
What is being tested?
The DALC Digital Clinic, a multidisciplinary online platform, is being tested to see if it can enhance the care of patients with ALD and AUD by improving health results, reducing costs, increasing access to care, and boosting satisfaction for both providers and patients.See study design
What are the potential side effects?
Since this trial involves the use of a digital clinic rather than medication or medical procedures, traditional side effects are not expected. However, participants may experience issues related to technology use such as eye strain or stress from learning new tools.

DALC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Median delta MELD-3.0 from baseline to end of study.
Secondary outcome measures
Greater provider satisfaction in DALC arm
Reduction of Number of hospitalizations
Sustained alcohol abstinence

DALC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Digital Clinic ArmExperimental Treatment1 Intervention
The Ria Treatment Platform (RTP) application will be downloaded onto the patient's smart phone or tablet.
Group II: Standard of Care ArmActive Control1 Intervention
Primary care providers will treat subject per standard of care utilizing the Interactive Care Plan program.

Find a Location

Who is running the clinical trial?

Ria HealthIndustry Sponsor
1 Previous Clinical Trials
124 Total Patients Enrolled
1 Trials studying Alcoholism
124 Patients Enrolled for Alcoholism
Mayo ClinicLead Sponsor
3,213 Previous Clinical Trials
3,766,971 Total Patients Enrolled
8 Trials studying Alcoholism
1,536 Patients Enrolled for Alcoholism
Douglas Simonetto, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
450 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently being actively sought for participation in this clinical trial?

"Affirmative. The information available on clinicaltrials.gov indicates that this research endeavor is actively seeking suitable candidates. Initially shared with the public domain on March 12, 2024, and subsequently revised on March 13, 2024, the trial aims to recruit a total of 40 participants from two distinct sites."

Answered by AI

What is the current size of the patient cohort being observed in this clinical investigation?

"Indeed, the details on clinicaltrials.gov affirm that this research study is presently in search of suitable candidates. The trial was initially made public on March 12th, 2024, and underwent its most recent update on March 13th, 2024. A total of 40 participants are sought from two designated sites."

Answered by AI

Who else is applying?

What site did they apply to?
Mayo Clinic
What portion of applicants met pre-screening criteria?
Met criteria
~27 spots leftby Sep 2024